These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32147864)

  • 1. High Interobserver Agreement in the Subjective Classification of 5-Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas.
    Mischkulnig M; Kiesel B; Borkovec M; Wadiura LI; Benner D; Hosmann A; Hervey-Jumper S; Knosp E; Roessler K; Berger MS; Widhalm G
    Lasers Surg Med; 2020 Nov; 52(9):814-821. PubMed ID: 32147864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
    Picart T; Pallud J; Berthiller J; Dumot C; Berhouma M; Ducray F; Armoiry X; Margier J; Guerre P; Varlet P; Meyronet D; Metellus P; Guyotat J;
    J Neurosurg; 2024 Apr; 140(4):987-1000. PubMed ID: 37856381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA.
    Muscas G; Orlandini S; Bonaudo C; Dardo M; Esposito A; Campagnaro L; Carrai R; Fainardi E; Ciccarino P; Della Puppa A
    Acta Neurochir (Wien); 2022 Dec; 164(12):3267-3274. PubMed ID: 36087121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery.
    Bettag C; Schregel K; Langer P; Thomas C; Behme D; Stadelmann C; Rohde V; Mielke D
    Neurosurg Focus; 2021 Jan; 50(1):E3. PubMed ID: 33386004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Fluorescence Using 5-Aminolevulinic Acid and Fluorescein Sodium at Glioblastoma Border: Intraoperative Findings and Histopathologic Data About 3 Newly Diagnosed Consecutive Cases.
    Della Puppa A; Munari M; Gardiman MP; Volpin F
    World Neurosurg; 2019 Feb; 122():e856-e863. PubMed ID: 30391771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.
    Díez Valle R; Tejada Solis S; Idoate Gastearena MA; García de Eulate R; Domínguez Echávarri P; Aristu Mendiroz J
    J Neurooncol; 2011 Mar; 102(1):105-13. PubMed ID: 20607351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
    Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
    Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
    Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
    Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, Outcome, and Safety of Elderly Patients with Glioblastoma in the 5-ALA Era: Single Center Experience of More Than 10 Years.
    Kiesel B; Wadiura LI; Mischkulnig M; Makolli J; Sperl V; Borkovec M; Freund J; Lang A; Millesi M; Berghoff AS; Furtner J; Woehrer A; Widhalm G
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-aminolevulinic enhanced brain lesions mimic glioblastoma: A case report and literature review.
    Chang CY; Chen CC
    Medicine (Baltimore); 2024 Jan; 103(1):e34518. PubMed ID: 38181251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
    J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
    Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
    J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
    Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
    J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver and intraobserver reliability of two classification systems for intra-articular calcaneal fractures.
    Lauder AJ; Inda DJ; Bott AM; Clare MP; Fitzgibbons TC; Mormino MA
    Foot Ankle Int; 2006 Apr; 27(4):251-5. PubMed ID: 16624214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Diagnostic Accuracy of Visible 5-ALA Fluorescence in Meningioma Surgery According to Histopathological Analysis of Tumor Bulk and Peritumoral Tissue.
    Wadiura LI; Millesi M; Makolli J; Wais J; Kiesel B; Mischkulnig M; Mercea PA; Roetzer T; Knosp E; Rössler K; Widhalm G
    Lasers Surg Med; 2021 Mar; 53(3):300-308. PubMed ID: 32608510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.